Precisely, it was established that at least one of the following alterations is necessary to compare them to a GBM since the lack of IDH mutation is not sufficient to confer a worse prognosis: EGFR-amp, pTERT-mut, the combined chromosome 7 gain, and chromosome 10 loss. This evidence concerns the gene IDH1 and glioblastoma.